Sleep Bootcamp: A Pilot Tele-Sleep Program for Former National Football League (NFL) Players
Pilot Study: Developing A Scalable Sleep Health Intervention to Improve Pain, Quality of Life, and Health in Former NFL Players
1 other identifier
interventional
42
1 country
1
Brief Summary
This pilot study is focused on estimating the impact of a tele-sleep intervention on patient-centered outcomes relevant to former football players, including a) sleep duration, quality, and daytime impairment; b) pain, pain catastrophizing, physical and emotional functioning; c) mood; d) quality of life, with the longer-term goal to evaluate the impact on cardiovascular health risk. The evidence-based 'Brief Behavioral Therapy for Insomnia' (BBTI) will be utilized and tailored it to meet the needs of former football players. This pilot work will serve as the foundation for a larger, future clinical trial that utilizes a durable approach for improving sleep health with potential influence pain and quality of life as well as future studies to evaluate the implementation and scalability of BBTI in novel populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2019
CompletedFirst Posted
Study publicly available on registry
November 12, 2019
CompletedStudy Start
First participant enrolled
January 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2020
CompletedSeptember 16, 2020
September 1, 2020
6 months
October 29, 2019
September 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance, 8b Endpoint
PROMIS Sleep Disturbance measures self-reported sleep quality and associated daytime functioning during the past seven days. The measure includes 8-items with higher scores indicating greater sleep disturbance. The minimum score is 8 and the maximum score is 40. Item responses are combined to yield a T-score with a population mean of 50 and standard deviation of 10.
Week 4
Secondary Outcomes (13)
PROMIS Sleep Disturbance, 8b Follow-up
Week 12
PROMIS Sleep Impairment, 8a Endpoint
Week 4
PROMIS Sleep Impairment, 8a Follow-up
Week 12
Response to treatment (baseline to endpoint)
Week 0 vs. Week 4
Response to treatment (baseline to follow-up)
Week 0 vs. Week 12
- +8 more secondary outcomes
Study Arms (1)
Adapted 'Brief Behavioral Therapy for Insomnia' (BBTI)
OTHERAll participants will receive the same intervention in this pilot study.
Interventions
Participants will receive evidence-based 'Brief Behavioral Therapy for Insomnia' (BBTI), tailored to meet the needs of former football players. BBTi is a brief, efficacious treatment that focuses on modifying behaviors, rather than cognitive domains. The treatment emphasizes education, motivational tools, and specific behavioral recommendations (e.g., restricting time in bed) and will be administered through weekly phone calls with a trained sleep interventionist over 4-weeks.
Eligibility Criteria
You may qualify if:
- Able to communicate clearly in English
- Have a digital device with reliable internet access
- Sub-clinical insomnia (Insomnia Severity Index, score \>7, sub-clinical threshold insomnia)
- Able to give informed consent
You may not qualify if:
- Prior participation in behavioral therapy for insomnia
- Self-reported circadian phase irregularity/delay, including regular shift work
- Previously diagnosed Narcolepsy, bipolar disorder or other major psychiatric disorders
- Active alcohol abuse (Alcohol Use Disorders Identification Test, AUDIT-C ≥4) or drug abuse (Drug Abuse Screening Test, DAST-2 ≥1)
- Current severe major depressive disorder (Patient Health Questionnaire-8, PHQ-8, score ≥20)
- Use of seizure medication or seizure within the past 10 years
- Untreated, previously diagnosed moderate to severe sleep apnea or excessive daytime sleepiness (defined by Epworth sleepiness scale score ≥16) with a self-reported sleep duration (\>6 hours)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suzanne Bertisch, MD, MPH
Assistant Professor in Medicine, Physician/Clinical Investigator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 29, 2019
First Posted
November 12, 2019
Study Start
January 14, 2020
Primary Completion
June 30, 2020
Study Completion
September 7, 2020
Last Updated
September 16, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share